Patel JD - Search Results

1

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

Gentzler RD, Yentz SE, Johnson ML, Rademaker AW, Patel JD. Gentzler RD, et al. Among authors: patel jd. Cancer. 2014 Dec 15;120(24):3853-8. doi: 10.1002/cncr.28956. Epub 2014 Aug 25. Cancer. 2014. PMID: 25155290 Free article.

2

Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.

Patel JD, Pasche B, Argiris A. Patel JD, et al. Crit Rev Oncol Hematol. 2004 Jun;50(3):175-86. doi: 10.1016/j.critrevonc.2004.02.004. Crit Rev Oncol Hematol. 2004. PMID: 15182824 Review.

3

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of bronchoalveolar carcinoma.

Patel JD. Patel JD. Clin Lung Cancer. 2004 Dec;6 Suppl 1:S43-7. doi: 10.3816/clc.2004.s.014. Clin Lung Cancer. 2004. PMID: 15638957 Review.

4

Induction chemotherapy for resectable non-small-cell lung cancer.

Patel JD, Blum MG, Argiris A. Patel JD, et al. Oncology (Williston Park). 2004 Nov;18(13):1591-602; discussion 1602-3, 1606, 1611-2. Oncology (Williston Park). 2004. PMID: 15648293 Review.

5

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.

Krug LM, Miller VA, Patel J, Crapanzano J, Azzoli CG, Gomez J, Kris MG, Heelan RT, Pizzo B, Tyson L, Sheehan C, Ross JS, Venkatraman E. Krug LM, et al. Cancer. 2005 Nov 15;104(10):2149-55. doi: 10.1002/cncr.21428. Cancer. 2005. PMID: 16208701 Free article. Clinical Trial.

6

Cytokine targeted treatments for lung cancer.

Patel J. Patel J. Cancer Treat Res. 2005;126:289-311. doi: 10.1007/0-387-24361-5_12. Cancer Treat Res. 2005. PMID: 16209071 Review. No abstract available.

7

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Johnson FM, Krug LM, Tran HT, Shoaf S, Prieto VG, Tamboli P, Peeples B, Patel J, Glisson BS. Johnson FM, et al. Cancer. 2006 Jan 15;106(2):366-74. doi: 10.1002/cncr.21640. Cancer. 2006. PMID: 16342249 Free article. Clinical Trial.

8

The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.

Fidler MJ, Argiris A, Patel JD, Johnson DH, Sandler A, Villaflor VM, Coon J 4th, Buckingham L, Kaiser K, Basu S, Bonomi P. Fidler MJ, et al. Among authors: patel jd. Clin Cancer Res. 2008 Apr 1;14(7):2088-94. doi: 10.1158/1078-0432.CCR-07-4013. Clin Cancer Res. 2008. PMID: 18381949 Clinical Trial.

9

Improving health-related quality of life in non-small-cell lung cancer with current treatment options.

Cella DF, Patel JD. Cella DF, et al. Among authors: patel jd. Clin Lung Cancer. 2008 Jul;9(4):206-12. doi: 10.3816/CLC.2008.n.030. Clin Lung Cancer. 2008. PMID: 18650167 Review.

10

Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.

Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Nonzee NJ, et al. Among authors: patel jd, patel u. Cancer. 2008 Sep 15;113(6):1446-52. doi: 10.1002/cncr.23714. Cancer. 2008. PMID: 18683883 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page